Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVRx, Inc.CVRX · Entity 6920 | Director | June 01, 2026 | June 03, 2026 |
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVRx, Inc.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,720 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 8,720 · Balance 8,720 F1: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.43 · Expires 2036-06-01 | Direct | 11,182 |
Reported balance
After 2026-06-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-01 · Grant · Acquired 11,182 · Balance 11,182 F1: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.6103 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.5195 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.1836 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.486 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 4.2988 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2025 Filed Mar 31, 2025 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8214 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010301 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.8313 Underlying: Common Stock · 0.8214 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.4803 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010301 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6111 Underlying: Common Stock · 0.4803 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.4803 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010301 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.5998 Underlying: Common Stock · 0.4803 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006163 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.0099 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006163 · rdgdoc.xml · nonDerivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006163 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,935 F1 · shares: These shares represent LMAT common stock acquired on February 28, 2025, upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years. F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:54 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037497 · rdgdoc.xml · derivative · entry 4 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.1308 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:54 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037497 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1195 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:54 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037497 · rdgdoc.xml · nonDerivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:54 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037497 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037276 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.0099 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037276 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 2,594 | $0.00 Strike: $101.12 | $0.00 |
DisclosureSEC source: 0001437749-24-037142 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,594 Underlying: Common Stock · 2,594 shares Expires 2029-12-06 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:39 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037142 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,724 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8043 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037042 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.0099 Underlying: Common Stock · 0.8043 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6284 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037042 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.1308 Underlying: Common Stock · 0.6284 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 10, 2024 00:17 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6284 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037042 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.1195 Underlying: Common Stock · 0.6284 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 22:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,070 | $47.19 Strike: $47.19 | $50,493.30 |
DisclosureSEC source: 0001437749-24-035513 · rdgdoc.xml · derivative · entry 4 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,139 Underlying: Common Stock · 1,070 shares Expires 2027-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 22:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 396 | $103.38 | $40,937.09 |
DisclosureSEC source: 0001437749-24-035513 · rdgdoc.xml · nonDerivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,304 Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 22:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 1,070 | $103.37 | $110,610.18 |
DisclosureSEC source: 0001437749-24-035513 · rdgdoc.xml · nonDerivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,700 Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 22:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,070 | $47.19 | $50,493.30 |
DisclosureSEC source: 0001437749-24-035513 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 29, 2024 Filed Sep 4, 2024 00:05 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9285 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028313 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.2056 Underlying: Common Stock · 0.9285 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 4, 2024 00:05 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.7254 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028313 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.5024 Underlying: Common Stock · 0.7254 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 4, 2024 00:05 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.7254 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028313 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7.4911 Underlying: Common Stock · 0.7254 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 23:05 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 20,961 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-015847 · form4-06062024_110622.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,961 Underlying: Common Stock · 20,961 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 7, 2024 21:16 UTC Amendment | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 27,250 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-016034 · form4a-06072024_090624.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2034-06-04 F1 · shares: The reporting person's Form 4 filed on June 6, 2024 inadvertently understated the reporting person's stock options granted by 6,289. F2 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.0426 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019079 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.2771 Underlying: Common Stock · 1.0426 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8146 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019079 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.777 Underlying: Common Stock · 0.8146 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 21:30 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8146 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019079 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.7657 Underlying: Common Stock · 0.8146 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.2345 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010438 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.2345 Underlying: Common Stock · 1.2345 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/23 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9644 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010438 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.9624 Underlying: Common Stock · 0.9644 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.9644 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010438 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.9511 Underlying: Common Stock · 0.9644 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1.9887 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006511 · rdgdoc.xml · derivative · entry 3 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.998 Underlying: Common Stock · 1.9887 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006511 · rdgdoc.xml · nonDerivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 593 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006511 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,699 F1 · shares: These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years. F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034348 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.9867 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034348 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 23:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 2,772 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0001437749-23-034245 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,772 Underlying: Common Stock · 2,772 shares Expires 2028-12-08 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 23:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034245 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,105 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5871 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033498 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6 Underlying: Common Stock · 1.5871 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4433 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025199 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.4 Underlying: Common Stock · 1.4433 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 20:12 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 12,012 | $0.00 Strike: $12.33 | $0.00 |
DisclosureSEC source: 0001415889-23-009358 · form4-06072023_080633.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Common Stock · 12,012 shares Expires 2033-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 5, 2024 or the Issuer's 2024 annual meeting of stockholders. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:28 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.2968 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-016640 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.96 Underlying: Common Stock · 1.2968 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 12:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6595 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-007968 · rdgdoc.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.6595 Underlying: Common Stock · 1.6595 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/22 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 22:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 3,209 | $0.00 Strike: $47.19 | $0.00 |
DisclosureSEC source: 0001437749-22-029007 · rdgdoc.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,209 Underlying: Common Stock · 3,209 shares Expires 2027-12-12 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 22:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 593 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-029007 · rdgdoc.xml · nonDerivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 593 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:41 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 26,985 | $0.00 Strike: $6.76 | $0.00 |
DisclosureSEC source: 0001415889-22-006374 · form4-06092022_010652.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,985 Underlying: Common Stock · 26,985 shares Expires 2032-06-06 F1 · derivative.exercise_date: Vests on the earlier of June 7, 2023 or the Issuer's 2023 annual meeting of stockholders. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 23:43 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 24,885 | $0.00 Strike: $20.10 | $0.00 |
DisclosureSEC source: 0001179110-21-007485 · edgar.xml · derivative · entry 2 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,885 Underlying: Common Stock · 24,885 shares Expires 2031-07-11 F2 · derivative.exercise_date: Vests as to one-third of the shares on each annual anniversary of the date of grant. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 23:43 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 9,988 | $0.00 Strike: $20.10 | $0.00 |
DisclosureSEC source: 0001179110-21-007485 · edgar.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,988 Underlying: Common Stock · 9,988 shares Expires 2031-07-11 F1 · derivative.exercise_date: Vests on the earlier of July 12, 2022 or the Issuer's 2022 annual meeting of stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.